Neirg Wealth Management, LLC Abb Vie Inc. Transaction History

Neirg Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $7.44 Million - $9.26 Million	-56,178 Reduced 92.56%	4,513 $608,000
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $299,487 - $344,904	-2,071 Reduced 3.3%	60,691 $9.67 Million
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $3,457 - $4,146	-25 Reduced 0.04%	62,762 $10.1 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $82,941 - $95,128	-618 Reduced 0.97%	62,787 $8.43 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $733,101 - $932,011	5,327 Added 9.17%	63,405 $9.71 Million
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $132,639 - $164,568	1,005 Added 1.76%	58,078 $9.42 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $6.13 Million - $7.76 Million	57,073 New	57,073 $7.73 Million

4,064

1.28B

17.8M

15.7M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Neirg Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Neirg Wealth Management, LLC with notifications on news.